Journal of Clinical Respiratory Medicine

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Clinical Respiratory Medicine 44 7897 074717

Opinion Article - Journal of Clinical Respiratory Medicine (2025) Volume 9, Issue 1

High-Resolution CT in Lung Disease Diagnosis: A Modern Diagnostic Asset

James D. Chalmers *

Division of Molecular and Clinical Medicine, University of Dundee, UK

*Corresponding Author:
James D. Chalmers
Division of Molecular and Clinical Medicine, University of Dundee, UK
E-mail: j.chalmers@dundee.ac.uk

Received: 1-Mar-2025, Manuscript No. aajcrm-25-167783; Editor assigned: 4-Mar-2025, PreQC No. aajcrm-25-167783 (PQ) Reviewed:17-Mar-2025, QC No. aajcrm-25-167783Revised:24-Mar-2025, Manuscript No. aajcrm-25-167783; Published:31-Mar-2025, DOI: 10.35841/ aajcrm - 9.1.251

Citation: Chalmers J. High-resolution CT in lung disease diagnosis: A modern diagnostic asset. J Clin Resp Med. 2025;9(1):251

Visit for more related articles at Journal of Clinical Respiratory Medicine

Introduction

High-Resolution Computed Tomography (HRCT) has revolutionized the diagnosis and management of lung diseases by providing detailed imaging of pulmonary structures. Unlike standard chest radiography or conventional CT scans, HRCT delivers highly precise cross-sectional images that can detect subtle changes in lung parenchyma, interstitial spaces, and airway anatomy [1].

HRCT plays a pivotal role in diagnosing a wide range of lung diseases, including interstitial lung diseases (ILDs), bronchiectasis, sarcoidosis, emphysema, and occupational lung disorders [2].

It enables clinicians to visualize specific patterns such as ground-glass opacities, reticulations, honeycombing, and nodular formations, which are critical in identifying the underlying pathology and distinguishing between similar clinical conditions [3].

In particular, HRCT is invaluable for early-stage disease detection and for monitoring disease progression or response to treatment. For example, in idiopathic pulmonary fibrosis (IPF), HRCT is the preferred imaging modality to evaluate the extent of fibrosis and assess prognosis without the need for invasive procedures like surgical lung biopsy [4].

Furthermore, the non-invasive nature and high diagnostic yield of HRCT make it an essential tool in clinical practice. When integrated with clinical history and pulmonary function tests, HRCT significantly enhances diagnostic accuracy and aids in personalized treatment planning [5].

Conclusion

High-Resolution CT has become an indispensable component in the diagnostic arsenal for pulmonary medicine, offering clarity, speed, and precision in evaluating complex lung pathologies.

References

  1. Alfonso AF, Suárez KM, Bautista CX, et al. New perspectives on advances in diagnosis through imaging in chronic respiratory diseases: A systematic literature review. Int J Interdiscip Stud. 2024;5(1):e24019-.

    2. Indexed at, Google Scholar, Cross Ref

  2. Chantzi SL, Kosvyra A, Chouvarda I. Radiomics and artificial intelligence in pulmonary fibrosis. J Imaging Inform Med. 2025:1-4.

    3. Indexed at, Google Scholar, Cross Ref

  3. Albers J, Wagner WL, Fiedler MO, et al. High resolution propagation-based lung imaging at clinically relevant X-ray dose levels. Sci Rep. 2023;13(1):4788.

    4. Indexed at, Google Scholar, Cross Ref

  4. Bautista-Sanchez R, Khanna D. Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?. Rheumatol Immunol Res. 2024;5(3):157-65.

    5. Indexed at, Google Scholar, Cross Ref

  5. Yates DH, Perret JL, Davidson M, et al. Dust diseases in modern Australia: A discussion of the new TSANZ position statement on respiratory surveillance. Med J Aust. 2021;215(1).

    6. Indexed at, Google Scholar, Cross Ref

Get the App